Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Ultrapar
UGP
$7.18B
| $339K | ﹤0.01% |
62,522
+4,665
| +8% | +$21.5K |
|
2027
Sprout Social
SPT
$607M
| $339K | ﹤0.01% |
5,515
-29,862
| -84% | -$1.57M |
|
2028
Goosehead Insurance
GSHD
$2.58B
| $338K | ﹤0.01% |
4,453
+419
| +10% | +$30.3K |
|
2029
Anterix
ATEX
$1.83B
| $336K | ﹤0.01% |
+10,087
| New | +$325K |
|
|
RPT
2030
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $336K | ﹤0.01% |
26,188
-36,644
| -58% | -$417K |
|
|
INFN
2031
DELISTED
Infinera Corporation Common Stock
INFN
| $336K | ﹤0.01% |
70,722
-98,468
| -58% | -$387K |
|
2032
Clean Energy Fuels
CLNE
$357M
| $335K | ﹤0.01% |
87,552
+51,854
| +145% | +$189K |
|
2033
Dimensional US Marketwide Value ETF
DFUV
$15.9B
| $335K | ﹤0.01% |
+9,007
| New | +$310K |
|
2034
ACV Auctions
ACVA
$1.26B
| $334K | ﹤0.01% |
22,055
-5,831
| -21% | -$85.4K |
|
2035
TriNet
TNET
$3.24B
| $333K | ﹤0.01% |
2,797
+578
| +26% | +$66.1K |
|
2036
NeoGenomics
NEO
$2.18B
| $330K | ﹤0.01% |
20,419
+8
| +0% | +$131 |
|
2037
Oscar Health
OSCR
$9.89B
| $328K | ﹤0.01% |
35,867
-36,294
| -50% | -$250K |
|
2038
Service Corp International
SCI
$11.4B
| $326K | ﹤0.01% |
4,765
+157
| +3% | +$9.45K |
|
2039
Advanced Energy
AEIS
$11.4B
| $325K | ﹤0.01% |
2,983
-504
| -14% | -$49K |
|
2040
Construction Partners
ROAD
$6.37B
| $324K | ﹤0.01% |
7,451
+95
| +1% | +$3.89K |
|
2041
Evolution Petroleum
EPM
$127M
| $323K | ﹤0.01% |
55,639
+39,926
| +254% | +$244K |
|
2042
State Street Financial Select Sector SPDR ETF
XLF
$56B
| $321K | ﹤0.01% |
8,547
+92
| +1% | +$3.19K |
|
2043
Icon
ICLR
$13.3B
| $321K | ﹤0.01% |
1,135
+131
| +13% | +$33.9K |
|
2044
Walker & Dunlop
WD
$1.38B
| $318K | ﹤0.01% |
2,861
-134
| -4% | -$11K |
|
2045
Companhia Siderúrgica Nacional
SID
$1.3B
| $318K | ﹤0.01% |
80,812
+8,435
| +12% | +$24.4K |
|
2046
National Health Investors
NHI
$3.6B
| $317K | ﹤0.01% |
5,684
-6,324
| -53% | -$335K |
|
2047
iShares Core S&P US Value ETF
IUSV
$28B
| $316K | ﹤0.01% |
3,750
| – | – |
|
2048
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.21B
| $313K | ﹤0.01% |
+12,163
| New | +$338K |
|
2049
Viavi Solutions
VIAV
$9.6B
| $313K | ﹤0.01% |
31,079
-74,378
| -71% | -$625K |
|
2050
Enpro
NPO
$6.62B
| $313K | ﹤0.01% |
+1,995
| New | +$258K |
|
Similar funds
Cliff Asness's Q4 2023 Portfolio in Review
As of Q4 2023, Cliff Asness held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Cliff Asness's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Cliff Asness's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- Cliff Asness added most to Amazon in Q4 2023, an estimated $144M increase.
- Cliff Asness's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- Cliff Asness fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- Cliff Asness's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- Cliff Asness opened 186 new positions and closed 172 in Q4 2023.
- Cliff Asness's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.